Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
TYPES OF MENTAL ILLNESS OVERVIEW • DEPRESSION • ANXIETY • SUBSTANCE ABUSE DEPRESSION • UNLIKE SCHIZ AND BIPOLAR • MUCH MORE COMMON – ESPECIALLY RECENTLY • “AGE OF DEPRESSION” ADULT PREVALENCE 25 20 15 10 5 0 1 year lifetime Treatment for Depression 4 3.5 3 2.5 2 % of pop. 1.5 1 0.5 0 1981-82 1991-92 2001-02 Diagnoses in Psychotherapy 40 35 30 25 1987 1997 20 15 10 5 0 Depression Depression Articles 1966-2001 7000 6000 5000 4000 3000 2000 1000 0 1966 1970 1974 1978 1982 1986 1990 1994 1998 Publications Psychotropic Prescribing in USA (IMS - S Units) 10000000 9000000 8000000 7000000 6000000 5000000 4000000 3000000 2000000 1000000 0 Antidepressant Antipsychotic 1990 1992 1994 1996 1998 2000 2001 MOOD • EITHER (OR BOTH) PRESENCE OF NEGATIVE MOOD • OR ABSENCE OF POSITIVE MOOD PHYSICAL SYMPTOMS • • • • LOW ENERGY, FATIGUE SLEEP DISTURBANCES APPETITE DISTURBANCES VULNERABILITY TO MANY PHYSICAL ILLNESSES PSYCHOLOGICAL SYMPTOMS • EMOTIONAL - SADNESS, APATHY, LACK OF PLEASURE • COGNITIVE - HOPELESSNESS AND HELPLESSNESS, LOW SELF-ESTEEM • BEHAVIORAL - WITHDRAWAL, SUICIDE ATTEMPTS TYPES OF DEPRESSION • CONTINUOUS • HOW SEVERE AND HOW LONG TYPES • MAJOR DEPRESSION - ABOVE • PSYCHOTIC (MELANCHOLIC) - MORE SEVERE, IMMOBILE, SUICIDAL • DYSTHYMIA – LOWER LEVEL BUT LONGER LASTING (TWO YEARS) • DISTRESS - REACTIVE TO LIFE EVENT, GOES AWAY WHEN CONDITIONS CHANGE, NOT A DISORDER CAUSES • • • • • VARIED CURRENT LOSSES AND TRAUMAS CHRONIC OPPRESSIVE SITUATIONS EARLY LOSS EVENTS AND ABUSE SOME GENETIC/BIOLOGICAL CHARACTERISTICS • GREAT VARIANCE ACROSS SOCIETIES (3% - 30%) • IN U.S. 10% EACH YEAR; 20% OVER LIFETIME • 2/3 WOMEN • INVERSE WITH SOCIAL CLASS • MOST AMONG YOUNG, ELDERLY PROGNOSIS (COURSE) • COURSE HIGHLY VARIABLE • MDD USUALLY RECURRENT • AVERAGE EPISODE ABOUT 3 - 6 MONTHS • DYSTHYMIA CHRONIC • DISTRESS ENDS WITH POSITIVE EVENTS TREATMENT • TREATED WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRI) - PROZAC, PAXIL, XOLOFT • NOT MORE EFFECTIVE THAN EARLIER DRUGS • FEWER SIDE EFFECTS, BETTER TOLERATED, LESS ADDICTIVE, FEWER OVERDOSES • HIGHER RISK OF SUICIDE? TREATMENT (CONT.) • COGNITIVE THERAPY • PSYCHOTHERAPY • COMBINATION OF DRUGS AND PSYCHOLOGICAL THERAPY MIGHT BE BEST SYMPTOMS • PSYCHOLOGICAL • UNEASE, FEAR, WORRY, ANXIOUSNESS, DREAD • PHYSICAL • HEART PALPITATIONS, TREMBLING, STOMACH UPSET, FAINTING MAJOR TYPES • PHOBIAS - INTENSE FEAR OF A SPECIFIC OBJECT OR SITUATION • PANIC - SITUATIONAL, EPISODIC • GENERALIZED ANXIETY DISORDER MAJOR TYPES • OBSESSIVE-COMPULSIVE PREOCCUPYING THOUGHTS OR BEHAVIORS MAJOR TYPES • SOCIAL ANXIETY DISORDER MAJOR TYPES • POST-TRAUMATIC STRESS DISORDER COMORBIDITY • VERY HIGH COMORBIDITY WITH DEPRESSION • MOST DEPRESSED PEOPLE ALSO ANXIOUS • ANXIOUS PEOPLE OFTEN DEPRESSED CHARACTERISTICS • GREAT VARIANCE ACROSS SOCIETIES • IN U.S. 20% EACH YEAR, 30% OVER LIFETIME SOCIAL CHARACTERISTICS • 2/3 FEMALE • HIGH ETHNIC VARIATION • E.G. BLACKS MORE PHOBIAS, HISPANICS MORE PANIC, JEWS MORE OBSESSIVE-COMPULSIVE TREATMENT • • • • MEDICATION SSRI’S ANTI-ANXIETY - XANAX BEHAVIOR THERAPY SUBSTANCE DEPENDENCE/ABUSE • DEPENDENCE • FREQUENT AND EXCESSIVE USE • GROWING TOLERANCE/PROBLEMS WITH WITHDRAWAL • ABUSE • PROBLEMATIC CONSEQUENCES OF USE - FAMILY, WORK, LEGAL CHARACTERISTICS • ALCOHOL ABUSE OR DEPENDENCE 10% YEAR, 25% LIFETIME • DRUG ABUSE OR DEPENDENCE - 3% YEAR; 12% LIFETIME CHARACTERISTICS • • • • • 2/3 MALE YOUNG PEOPLE MIXED RESULTS ON SOCIAL CLASS MUCH ETHNIC VARIATION E.G. ISLAMIC, ASIANS, JEWS LITTLE, IRISH AND EASTERN EUROPE MUCH, BLACKS CURVILINEAR TREATMENT • • • • VARIATION IN TREAT OR PUNISH? MUCH TREATMENT INVOLUNTARY GROUP THERAPY - AA SOME MEDICATION